Latest Breaking News On - ஜெஃப் ம்கிலௌஊகிலின் - Page 9 : comparemela.com
County seeks ways to stop decades-long population decline
ncadvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncadvertiser.com Daily Mail and Mail on Sunday newspapers.
County seeks ways to stop decades-long population decline
ctpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ctpost.com Daily Mail and Mail on Sunday newspapers.
Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: GSK announces otilimab data for treatment of COVID
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
· New Phase 2 study assesses potential for refined antigen formulation to achieve optimal immune response, including in older adults · If results are positive, Phase 3 study to start in Q2 2021, with vaccine expected to be available in Q4 2021 · In parallel, development work on new SARS-CoV-2 variants underway Sanofi and GlaxoSmithKline (GSK) announced today the initiation of a new Phase 2 study with 720 volunteers aged 18 and over to select the most appropriate antigen dosage for Phase 3 evaluation of their adjuvanted recombinant protein COVID-19 vaccine candidate. Over the past few weeks, our teams have worked to refine the antigen formulation of our recombinant-protein vaccine, based on learnings from our initial Phase 1/2 study. said Thomas Triomphe, Executive Vice President and Head of Sanofi Pasteur. We are confident that our vaccine candidate has strong potential